Nexgel (NXGL) Capital Expenditures Growth (3y) (2023 - 2025)
Nexgel (NXGL) Capital Expenditures Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.93 Bn | 121.71 Bn | 1.96 Bn | -29.93% |
| 2 | Becton Dickinson | 44.94 Bn | 44.13 Bn | 2.15 Bn | -11.61% |
| 3 | Alcon | 33.13 Bn | 31.47 Bn | 1.53 Bn | -10.15% |
| 4 | Medline | 32.87 Bn | 30.63 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 5.31% |
| 6 | West Pharmaceutical Services | 23.28 Bn | 22.84 Bn | 329.20 Mn | -16.94% |
| 7 | Solventum | 14.11 Bn | 13.55 Bn | 1.10 Bn | 8.92% |
| 8 | Cooper Companies | 13.80 Bn | 13.66 Bn | 735.40 Mn | 5.49% |
| 9 | Align Technology | 12.06 Bn | 11.00 Bn | 736.59 Mn | -21.70% |
| 10 | Nexgel | 3.53 Mn | 1.73 Mn | 819,000.00 | 71.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 71.00% |
| Sep 30, 2025 | -48.03% |
| Dec 31, 2024 | 36.98% |
| Sep 30, 2024 | -52.72% |
| Mar 31, 2024 | -17.12% |
| Dec 31, 2023 | -19.01% |
| Sep 30, 2023 | 67.63% |
| Jun 30, 2023 | 30.06% |
| Mar 31, 2023 | 344.80% |